Related Experiment Video
Updated: Jun 10, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with
Na Li1, Hongjun Bian, Juan Zhang
1The Key Laboratory of Cardiovascular Remodeling and Function Research of Chinese Ministry of Education and Public Health, Shandong University Qilu Hospital, 250012 Jinan, Shandong Province, China.
Insights
Chronic heart failure (CHF) is linked to an imbalance between T helper 17 (Th17) cells and regulatory T (Treg) cells. This study found higher Th17 and lower Treg frequencies in CHF patients, suggesting a potential therapeutic target.
Area of Science:
- Immunology
- Cardiology
- Inflammation research
Background:
- Immune activation and inflammation are key drivers in chronic heart failure (CHF) progression.
- T helper (Th) lymphocytes, specifically Th17 and regulatory T (Treg) cells, play critical roles in immune regulation.
- The balance between Th17 and Treg cells is crucial for controlling inflammation and autoimmune responses.
Purpose of the Study:
- To investigate the hypothesis that the Th17/Treg cell balance is disrupted in patients with chronic heart failure (CHF).
- To compare Th17 and Treg cell frequencies in different subgroups of CHF patients and healthy controls.
Main Methods:
- Patients with CHF were categorized into two groups: heart failure with normal ejection fraction (HFNEF) and heart failure with reduced ejection fraction (HFREF).
- Peripheral blood samples were analyzed using flow cytometry to quantify the frequencies of Th17 and Treg cells.
Main Results:
- Both HFNEF and HFREF patient groups exhibited a significant increase in Th17 cell frequencies compared to control groups.
- A notable decrease in Treg cell frequencies was observed in both HFNEF and HFREF patients relative to controls.
Conclusions:
- The findings confirm a Th17/Treg cell imbalance in patients suffering from CHF.
- This immune dysregulation may contribute to the pathogenesis of CHF.
- Restoring the Th17/Treg balance presents a potential therapeutic strategy for managing CHF.
Background:
Immune activation and inflammation participate in the progression of chronic heart failure (CHF), and T helper (Th) lymphocytes play critical roles in it. Th17 cells and CD4(+)CD25(+) regulatory T (Treg) cells both come from naive Th cells, share reciprocal development pathways but exhibit opposite effects, and the balance between them controls inflammation and autoimmune diseases. We hypothesized that the Th17/Treg balance was impaired in patients with CHF.
Methods:
To assess our hypothesis, patients with CHF were divided into 2 groups: heart failure with normal ejection fraction (HFNEF) group and heart failure with reduced ejection fraction (HFREF) group. Peripheral Th17 and Treg frequencies were analyzed by flow cytometry.
Results:
Patients with HFNEF and HFREF both revealed significant increase in the frequencies of Th17 and obvious decrease in the frequencies of Treg compared with the controls.
Conclusion:
The results indicate that the Th17/Treg imbalance exists in patients with CHF, suggesting the imbalance potentially plays a role in the pathogenesis, and the Th17/Treg balance may be a promising therapeutic approach in patients with CHF.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
